#160692

Anti-CEACAM1-dN [3-9F-3G]

Cat. #160692

Anti-CEACAM1-dN [3-9F-3G]

Cat. #: 160692

Sub-type: Primary antibody

Unit size: 100 ug

Availability: 10-12 weeks

Target: recombinant CEACAM1-dN-Fc (mAb does not bind the N domain)

Class: Monoclonal

Application: ELISA ; FACS ; IHC ; IF ; IP ; WB

Reactivity: Human

Host: Mouse

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Institute: LeukoCom

Tool Details
Target Details
Applications
Handling

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: Anti-CEACAM1-dN [3-9F-3G]
  • Research fields: Cancer;Cell biology
  • Tool sub type: Primary antibody
  • Class: Monoclonal
  • Conjugation: Unconjugated
  • Molecular weight: 100 kDa
  • Reactivity: Human
  • Host: Mouse
  • Application: ELISA ; FACS ; IHC ; IF ; IP ; WB
  • Description: Epithelia, endothelia and leukocyte expression and sera of macaque; potential tumor marker
  • Immunogen: recombinant human CEACAM1-Fc protein
  • Immunogen uniprot id: P13688
  • Myeloma used: NS1/0
  • Recommended controls: IgG1 kappa

Target Details

  • Target: recombinant CEACAM1-dN-Fc (mAb does not bind the N domain)
  • Molecular weight: 100 kDa
  • Tissue cell line specificity: IgG1 kappa
  • Target background: Epithelia, endothelia and leukocyte expression and sera of macaque; potential tumor marker

Applications

  • Application: ELISA ; FACS ; IHC ; IF ; IP ; WB

Handling

  • Format: Liquid
  • Concentration: 0.9-1.1 mg/ml
  • Unit size: 100 ug
  • Storage buffer: PBS with 0.02% azide
  • Storage conditions: -15° C to -25° C
  • Shipping conditions: Shipping at 4° C